Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/20255
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKatopodis, K. P.en
dc.contributor.authorKoliousi, E. L.en
dc.contributor.authorAndrikos, E.en
dc.contributor.authorPappas, M. V.en
dc.contributor.authorElisaf, M. S.en
dc.contributor.authorSiamopoulos, K. C.en
dc.date.accessioned2015-11-24T19:05:51Z-
dc.date.available2015-11-24T19:05:51Z-
dc.identifier.issn0160-564X-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/20255-
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectAgeden
dc.subjectDialysis Solutionsen
dc.subjectFemaleen
dc.subjectHomeostasisen
dc.subjectHumansen
dc.subjectKidney Failure, Chronic/blood/therapyen
dc.subjectMagnesium/*blooden
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subject*Peritoneal Dialysis, Continuous Ambulatoryen
dc.subjectRetrospective Studiesen
dc.subjectStatistics, Nonparametricen
dc.titleMagnesium homeostasis in patients undergoing continuous ambulatory peritoneal dialysis: role of the dialysate magnesium concentrationen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/12940910-
heal.identifier.secondaryhttp://onlinelibrary.wiley.com/store/10.1046/j.1525-1594.2003.07193.x/asset/j.1525-1594.2003.07193.x.pdf?v=1&t=h0npyk5v&s=7aa9a4e5bf814eb08530644502ef0a266a681792-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2003-
heal.abstractWe carried out this retrospective study to examine the magnesium status of our chronic ambulatory peritoneal dialysis (CAPD) patients dialyzed with 0.75 mmol/L (group I) or 0.50 mmol/L (group II) magnesium peritoneal dialysis solution. A total of 34 anuric patients on CAPD (age:31-72 years; duration of CAPD:7-74 months) were studied. None of them received magnesium-containing phosphate binders or vitamin D. Biochemical parameters including magnesium, calcium, phosphate, parathormone, and albumin were measured in all patients. The corrected for hypoalbuminemia serum magnesium concentration in group I was significantly higher compared to that found in group II. However, there were no significant differences in the other measured parameters between the two groups of CAPD patients, though iPTH levels were somewhat increased in group II patients. Serum magnesium levels were weakly correlated with serum prealbumin levels in both groups of CAPD patients (r=0.16, P=0.08 and r=0.17, P=0.07). The incidence of hypermagnesemia was significantly higher in group I patients versus those in group II (13/19 68.4%] vs. 2/15 13.3%], P<0.01). On the other hand, no patient developed hypomagnesemia (corrected total magnesium <0.65 mmol/L), despite the trend toward decreased magnesium levels in group II patients. Our results point out that serum iPTH levels and nutritional parameters, such as prealbumin levels, should be taken into account in the choice of the magnesium concentration of the peritoneal dialysis fluid.en
heal.journalNameArtif Organsen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Katopodis-2003-Magnesium homeostasi.pdf156.47 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons